The European Organisation for Research and Treatment of Cancer Quality of Life Questionnaire for patients with Bone Metastases: The EORTC QLQ-BM22

被引:96
|
作者
Chow, Edward [1 ]
Hird, Amanda [1 ]
Velikova, Galina [2 ]
Johnson, Colin [3 ]
Dewolf, Linda [4 ]
Bezjak, Andrea [5 ]
Wu, Jackson [6 ]
Shafiq, Jesmin [7 ]
Sezer, Orhan [8 ]
Kardamakis, Dimitrios [9 ]
van der Linden, Yvette [10 ]
Ma, Brigette [11 ]
Castro, Monica [12 ]
Foro Arnalot, Palmira [13 ]
Ahmedzai, Sam [14 ]
Clemons, Mark [5 ]
Hoskin, Peter [15 ]
Yee, Albert [1 ]
Brundaye, Michael [16 ]
Bottomley, Andrew [4 ]
机构
[1] Sunnybrook Hlth Sci Ctr, Toronto, ON M4N 3M5, Canada
[2] Univ Leeds, St James Univ Hosp, Canc Res UK Clin Ctr, Leeds, W Yorkshire, England
[3] Southampton Gen Hosp, Univ Surg Unit, Southampton, Hants, England
[4] European Org Res Treatment Canc, Brussels, Belgium
[5] Univ Toronto, Princess Margaret Hosp, Univ Hlth Network, Toronto, ON, Canada
[6] Univ Calgary, Tom Baker Canc Ctr, Calgary, AB, Canada
[7] Liverpool Hosp, Liverpool, NSW, Australia
[8] Univ Med Berlin, Charite, Berlin, Germany
[9] Univ Patras, Sch Med, GR-26110 Patras, Greece
[10] Radiotherapeut Inst Friesland, Leeuwarden, Netherlands
[11] Chinese Univ Hong Kong, Prince Wales Hosp, Shatin, Hong Kong, Peoples R China
[12] Univ Buenos Aires, Inst Oncol Angel H Roffo, RA-1053 Buenos Aires, DF, Argentina
[13] Hosp Esperanza, Barcelona, Spain
[14] St Lukes Hosp, Sheffield, S Yorkshire, England
[15] Mt Vernon Hosp, Northwood HA6 2RN, Middx, England
[16] Kingston Reg Canc Ctr, Kingston, ON, Canada
关键词
Bone metastases; Health-related quality of life; Questionnaire; Cancer; Pain symptoms; EORTC; SUPPORTIVE PAMIDRONATE TREATMENT; BREAST-CANCER; PROSTATE-CANCER; CONTROLLED-TRIAL; ZOLEDRONIC ACID; ORAL CLODRONATE; PAIN; IBANDRONATE; PLACEBO; CARCINOMA;
D O I
10.1016/j.ejca.2008.11.013
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Aim: The aim of this study was to develop a bone metastases module to supplement the European Organisation for Research and Treatment of Cancer Core Questionnaire (EORTC QLQ-C30) or the EORTC QLQ-C15-PAL for patients with bone metastases. Methods Phases 1-2 of module development were conducted in Canada, Australia and Germany according to EORTC QOL group guidelines. Phase 3 was conducted in nine countries in seven languages. Results: Sixty-one health-related quality of life (HRQOL) issues were generated from health care professionals (n = 152) and patients (n = 413). This resulted in a 22-item provisional module. Further testing in 170 patients from nine countries resulted in the EORTC QLQ-BM22 module, containing 22 items, conceptualised into both symptom scales, with five painful sites and three pain characteristics, and also functional scales, with eight functional interference and six psychosocial aspects. Conclusion: This study provides a provisional comprehensive HRQOL measurement tool for future trials, which will continue to undergo further validation. (C) 2008 Elsevier Ltd. All rights reserved.
引用
收藏
页码:1146 / 1152
页数:7
相关论文
共 50 条
  • [31] The European Organization for Research and Treatment of Cancer Quality of Life Questionnaire (EORTC QLQ-C30): Validation of English version in Singapore
    N. Luo
    C. S. L. Fones
    S. E. Lim
    F. Xie
    J. Thumboo
    S. C. Li
    Quality of Life Research, 2005, 14 : 1181 - 1186
  • [32] The effects of age on health-related quality of life in cancer populations: A pooled analysis of randomized controlled trials using the European Organisation for Research and Treatment of Cancer (EORTC) QLQ-C30 involving 6024 cancer patients
    Quinten, Chantal
    Coens, Corneel
    Ghislain, Irina
    Zikos, Efstathios
    Sprangers, Mirjam A. G.
    Ringash, Jolie
    Martinelli, Francesca
    Ediebah, Divine E.
    Maringwa, John
    Reeve, Bryce B.
    Greimel, Eva
    King, Madeleine T.
    Bjordal, Kristin
    Flechtner, Hans-Henning
    Schmucker-Von Koch, Joseph
    Taphoorn, Martin J. B.
    Weis, Joachim
    Wildiers, Hans
    Velikova, Galina
    Bottomley, Andrew
    EUROPEAN JOURNAL OF CANCER, 2015, 51 (18) : 2808 - 2819
  • [33] The European Organization for Research and Treatment of Cancer Quality of Life Questionnaire (EORTC QLQ-C30): translation and validation study of the Iranian version
    A. Montazeri
    Iraj Harirchi
    Mariam Vahdani
    Fatemeh Khaleghi
    Soghra Jarvandi
    Mandana Ebrahimi
    Mehregan Haji-Mahmoodi
    Supportive Care in Cancer, 1999, 7 : 400 - 406
  • [34] Phase III study of the European Organisation for Research and Treatment of Cancer Quality of Life cancer survivorship core questionnaire
    van Leeuwen, Marieke
    Kieffer, Jacobien M.
    Young, Teresa E.
    Aaronson, Neil K.
    Van de Poll-Franse, Lonneke V.
    JOURNAL OF CANCER SURVIVORSHIP, 2023, 17 (04) : 1111 - 1130
  • [35] The European Organization for Research and Treatment of Cancer Quality of Life Questionnaire (EORTC QLQ-C30): translation and validation study of the Iranian version
    Montazeri, A
    Harirchi, I
    Vahdani, M
    Khaleghi, F
    Jarvandi, S
    Ebrahimi, M
    Haji-Mahmoodi, M
    SUPPORTIVE CARE IN CANCER, 1999, 7 (06) : 400 - 406
  • [36] Cross-Cultural Application of the Korean Version of the European Organization for Research and Treatment of Cancer Quality of Life Questionnaire for Patients with Prostate Cancer - EORTC QLQ-PR25
    Park, Jinsung
    Shin, Dong Wook
    Yun, Seok Joong
    Park, Sung-Woo
    Jeon, Seong Soo
    Kwak, Cheol
    Kwon, Tae Gyun
    Kim, Hyung Jin
    Ahn, Hanjong
    ONCOLOGY, 2013, 85 (05) : 299 - 305
  • [37] A prospective study to validate the Polish language version of the European Organisation for Research and Treatment of Cancer (EORTC) Colorectal Liver Metastases (QLQ-LMC21) module
    Paradowska, Dominika
    Bereza, Krzysztof
    Sanna, Beatrice
    Kucharska, Ewa
    Tomaszewska, Iwona M.
    Dudkiewicz, Zbigniew
    Skotnicki, Piotr
    Bottomley, Andrew
    Tomaszewski, Krzysztof A.
    EUROPEAN JOURNAL OF ONCOLOGY NURSING, 2017, 29 : 148 - 154
  • [38] Independent psychometric validation of European Organization for Research and Treatment of Cancer Quality of Life Questionnaire-Endometrial Cancer Module (EORTC QLQ-EN24)
    Stukan, M.
    Zalewski, K.
    Mardas, M.
    Filarska, D.
    Szajewski, M.
    Kmiec, A.
    Binkowska, P.
    Pietrzak-Stukan, M.
    Dudziak, M.
    Grabowski, J. P.
    Eskander, R. N.
    Greimel, E.
    EUROPEAN JOURNAL OF CANCER CARE, 2018, 27 (01)
  • [39] Cross-Cultural Adaptation and Pilot Psychometric Validation of the European Organisation for Research and Treatment of Cancer-Quality of Life Questionnaire-Sexual Health (EORTC QLQ-SH22) Scale, Moroccan Arabic Version
    Mahlaq, Safiya
    Rais, Ghizlane
    Abouqal, Redouane
    Belayachi, Jihane
    HEALTHCARE, 2024, 12 (18)
  • [40] International phase IV validation study of an EORTC quality of life questionnaire for testicular cancer patients: the EORTC QLQ-TC26
    Sztankay, Monika
    Aaronson, Neil K.
    Arraras, Juan I.
    Basso, Umberto
    Bumbasirevic, Uros
    Efficace, Fabio
    Giesinger, Johannes M.
    Johnson, Colin D.
    van Leeuwen, Marieke
    Oberguggenberger, Anne S.
    Sosnowski, Roman
    Young, Teresa
    Holzner, Bernhard
    BMC CANCER, 2018, 18